iShares Russell 2000 ETF (IWM)
- Previous Close
216.58 - Open
208.85 - Bid 208.52 x 800
- Ask 208.56 x 800
- Day's Range
208.42 - 210.91 - 52 Week Range
161.67 - 228.63 - Volume
13,865,130 - Avg. Volume
30,453,496 - Net Assets 60B
- NAV 216.81
- PE Ratio (TTM) 13.44
- Yield 1.30%
- YTD Daily Total Return 8.48%
- Beta (5Y Monthly) 1.06
- Expense Ratio (net) 0.19%
The fund generally invests at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index (i.e., depositary receipts representing securities of the underlying index) and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents.
iShares
Fund Family
Small Blend
Fund Category
60B
Net Assets
2000-05-22
Inception Date
Performance Overview: IWM
View MoreTrailing returns as of 8/1/2024. Category is Small Blend.
People Also Watch
Holdings: IWM
View MoreTop 10 Holdings (3.42% of Total Assets)
Sector Weightings
Recent News: IWM
View MoreResearch Reports: IWM
View MoreBiogen Earnings: Shares Undervalued as Cost Controls Materialize and New Launches Accelerate
Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva (oncology) and Ocrevus (multiple sclerosis) are marketed via a collaboration with Roche. Biogen markets several multiple sclerosis drugs including Plegridy, Tysabri, Tecfidera, and Vumerity. Biogen's newer products include Spinraza (SMA, with partner Ionis), Leqembi (Alzheimers, with partner Eisai), Skyclarys (Friedreich's Ataxia, Reata), Zurzuvae (postpartum depression, Sage), and Qalsody (ALS, Ionis). Biogen has several drug candidates in phase 3 trials in neurology, immunology, and rare diseases.
RatingPrice TargetMcDonald's Set to Increase Investment in Value Positioning as Consumer Spending Slows
McDonald’s is the largest restaurant owner-operator in the world, with 2023 system sales of $130 billion across nearly than 42,000 stores and 115 markets. McDonald’s pioneered the franchise model, building its footprint through partnerships with independent restaurant franchisees and master franchise partners around the globe. The firm earns roughly 60% of its revenue from franchise royalty fees and lease payments, with most of the remainder coming from company-operated stores across its three core segments: the United States, internationally operated markets, and international developmental/licensed markets.
RatingPrice TargetPayPal Earnings: Focus on Profitable Growth Pays Off
PayPal was spun off from eBay in 2015 and provides electronic payment solutions to merchants and consumers, with a focus on online transactions. The company had 426 million active accounts at the end of 2023. The company also owns Venmo, a person-to-person payment platform.
RatingPrice TargetAlphabet Earnings: Search and Cloud Growth Remain Impressive
Alphabet is a holding company. Internet media giant Google is a wholly owned subsidiary. Google services account for nearly 90% of Alphabet's revenue, of which more than 85% is from online ads. Other Google services revenue is from sales of apps and content on Google Play and YouTube, as well as sales of hardware such as Chromebooks, the Pixel smartphone, and smart home products, which include Nest and Google Home. Google's cloud computing offerings account for a bit more than 10% of total Alphabet revenue. Alphabet’s moonshot investments are in its other bets segment, where it bets on technology to enhance health (Verily), provide faster internet access (Google Fiber), enable self-driving cars (Waymo), and more.
RatingPrice Target